Oncology
News
Drugs
Xagena Medicine
Xagena.net
Chemotherapy after surgery extends survival for patients with advanced endometrial cancer
Subtypes of ependymomas arise from rare stem cells in the nervous system
Retinoblastoma: combination therapy with Topotecan and Carboplatin
CDKN2A mutations have a modest impact on the incidence of melanoma
Nanoparticle-aptamer bioconjugates as targeted drug delivery
Chernobyl legacy sheds light on link between thyroid cancer and radiation exposure
MetAP2, a new target in neurofibromatosis 1
Rapid screen-and-treat methods for cervical cancer significantly reduce cancer precursor lesions
Young women who smoke higher risk of breask cancer
Type of childhood cancer and treatment received linked to physical problems later in life
Anti-inflammatory drugs may cut risk of esophageal cancer in people with Barrett's esophagus
Common viruses may cause cancer
No evidence that cholesterol drugs lower melanoma risk
Breast cancer: polymorphisms in Tamoxifen metabolizing genes affect clinical outcome
Cancers may cause surrounding supportive cells to grow and proliferate
Can most types of cancers be prevented ?
Women who undergo reconstructive breast implantation frequently develop short-term complications
Artificial light at night stimulates breast cancer growth in animal model
Artemisinin shows potential in preventing breast cancer
Screening chest x-ray detects early-stage lung cancers at high rates
Ultraviolet B light exposure associated with increased risk of skin cancer
White women with skin cancer history more likely to develop melanoma
Antibody therapy promising for neuroblastoma in a laboratory model
Cancer, epigenetic changes come before mutations
High grade renal cell carcinoma: Imatinib does not appear to be effective
Role of microRNA in papillary thyroid cancer
Vitamin D appears to lower the risk of developing cancers
EphA2, a novel target for glioblastoma multiforme
Risk of melanoma in CDKN2A mutation carriers lower than estimated
Herceptin plus adjuvant chemotherapy improves outcomes among women with surgically removed HER2-positive breast cancer
Next Pages
1
2
3
4
5
6
7
[
8
]
9
10
»
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions
